Naproxen
- Product NDC
- 10544-044
- 11-digit product format
- 105440044
- Labeler code
- 10544
- Product ID
- 10544-044_8eb3883b-e794-4d59-aa00-a870df172b97
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA075927
- Marketing category
- ANDA
- Marketing start
- 2011-05-04
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10544-044-20 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5920-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
| 10544-044-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5920-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
| 10544-044-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5920-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
| 10544-044-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5920-f424-e053-dadaa90a57ce | Naproxen Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10544-044-20 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 2 | |
| 10544-044-30 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 10544-044-60 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 10544-044-90 | Naproxen | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10544-044-20 | EA - Each | 10544-044 | 1ff1ba09-6ef3-4a19-b9ff-5362e04719d7 | 1 | 2015-05-05 |
| 10544-044-30 | EA - Each | 10544-044 | 41ccdc04-0871-4bc3-9d1e-60e0c9a71f75 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [BLENHEIM PHARMACAL, INC.] | 2 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [BLENHEIM PHARMACAL, INC.] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [BLENHEIM PHARMACAL, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [BLENHEIM PHARMACAL, INC.] | 2 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [BLENHEIM PHARMACAL, INC.] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198014 | naproxen 500 MG Oral Tablet | PSN | f4d9bd36-b960-47f6-afde-22f5012d419b | 2 |
| 198014 | naproxen 500 MG Oral Tablet | SCD | f4d9bd36-b960-47f6-afde-22f5012d419b | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 10544-044-20 | 10544004420 | 20 in 1 BOTTLE | Historical |
| 10544-044-30 | 10544004430 | 30 in 1 BOTTLE | Historical |
| 10544-044-60 | 10544004460 | 60 in 1 BOTTLE | Historical |
| 10544-044-90 | 10544004490 | 90 in 1 BOTTLE | Historical |